From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia.
Saez-Ayala M, Hoffer L, Abel S, Ben Yaala K, Sicard B, Andrieu GP, Latiri M, Davison EK, Ciufolini MA, Brémond P, Rebuffet E, Roche P, Derviaux C, Voisset E, Montersino C, Castellano R, Collette Y, Asnafi V, Betzi S, Dubreuil P, Combes S, Morelli X.
Saez-Ayala M, et al. Among authors: voisset e.
Nat Commun. 2023 May 29;14(1):3079. doi: 10.1038/s41467-023-38668-2.
Nat Commun. 2023.
PMID: 37248212
Free PMC article.